Benefits of Vitamin B9 (Folate)

Evidence-Based Benefits

• Neural tube defect prevention — the MRC Vitamin Study (1991, Lancet, n=1,817) demonstrated that 4 mg folic acid daily reduced NTD recurrence by 72%; CDC recommends all women of childbearing age consume 400 mcg daily
• Homocysteine reduction — folate (with B12 and B6) is essential for converting homocysteine to methionine; a 1998 meta-analysis found folic acid reduced homocysteine by 25%, a cardiovascular risk factor
• DNA synthesis and cell division — folate is required for thymidylate synthase (DNA production) and purine synthesis; deficiency causes megaloblastic anemia and impaired immune cell proliferation
• Mood and depression — methylfolate is a cofactor for SAMe production, which influences serotonin, dopamine, and norepinephrine synthesis; a 2012 meta-analysis found folate augmentation improved antidepressant response

What the Research Says

Folate has one of the most impactful public health evidence bases of any vitamin. The MRC Vitamin Study (1991, Lancet) definitively showed that 4 mg folic acid daily reduced neural tube defect recurrence by 72%, leading to mandatory fortification in 80+ countries. Since U.S. folic acid fortification began in 1998, NTD rates dropped by 28%. Homocysteine-lowering effects are well-established, with the Homocysteine Lowering Trialists' Collaboration (1998) meta-analysis showing 25% reduction. For depression, Papakostas et al. (2012) demonstrated in a multi-site RCT that L-methylfolate at 15 mg/day augmented SSRI response in treatment-resistant depression.

Related Conditions